This week’s episode examines the issue of discrimination in the workplace. The two most common forms of workplace discrimination involve race and gender issues. Beasley Allen Shareholder Larry Golston is a guest on the show this week. He has been with Beasley Allen for nearly 13 years, practicing in the areas of employment law, class action cases and insurance fraud and bad faith cases. Golston talks with show host Gibson Vance about how to recognize discrimination in the workplace. He says a person’s instincts are usually good, but there are ways to evaluate your situation to figure out if you may have a legal claim. First, he says, determine if you are part of a “protected class.” This is a legal term that specifically defines certain groups or types of people that cannot be discriminated against, whose rights are protected. These may include race, gender, age, national origin, religion and disability. Secondly, he says to look for either direct evidence or circumstantial evidence to support your claim of discrimination. Discrimination issues may involve someone being paid more than another for the same work, someone being passed over for promotions, or being subjected to a hostile work environment or even verbal or physical assault. Golston said it is very important to document your situation if you feel you are being discriminated against or harassed. He says laws are in place to protect workers from retaliation by their employer for bringing a complaint.
We're here to help!
We live by our creed of “helping those who need it most” and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.
In the News
Continuing the battle with Big Pharma
The entire Beasley Allen staff had our personal interest at heart. We were part of the family of a down to earth, trustworthy, understanding law firm. Thank you, Beasley Allen, for continuing the battle with Big Pharma.